drugset / Trial / NCT02533973

Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population

NCT02533973

Phase 4 Completed 951 enrolled LEO Pharma Tigermed Consulting Co., Ltd · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

A phase 4 trial comparing the safety and efficacy of treatment with Xamiol® gel (calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate)) once daily (as required) with Daivonex® scalp solution (calcipotriol 50 mcg/g) twice daily (as required) in Chinese subjects with scalp psoriasis

Timeline

Start
2015-09
Primary completion
2018-03-06
Completion
2018-03-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified 0.5 unknown Topical
Comparator Calcipotriol Small molecule 50 unknown Topical

Indications